...
首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles
【24h】

Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles

机译:封装在可生物降解微粒中的灭活霍乱弧菌全细胞疫苗的口服免疫原性

获取原文
获取原文并翻译 | 示例

摘要

Vibrio cholerae (VC)-loaded microparticles as an oral vaccine delivery system were prepared with 6% w/v poly(DL-lactide-co-glycolide)(PLG) in the oil phase as well as 10% w/v PVP and 5% w/v NaCl in the aqueous phase, by an water-in-oil-in-water emulsion/ solvent extraction technique. VC was successfully entrapped in the microparticles with trapping efficiencies up to 97.8% and a loading level of 55.4 +/- 6.9 mug/mg. The microparticle delivery system with a particle size of 3.8 mum had different distribution of VC content in the core region (25.7 +/- 1.9 mug/mg) and surface (6.2 +/- 0.9 mug/mg). The immunogenic potential of VC-loaded microparticles in comparison with PLG microparticles or VC solution was evaluated in adult mice by oral immunization, in which mice received one dose of 20 mg VC-loaded microparticles or 20 mg VC-loaded microparticles physical mixed with amphotericin B. The control group received 20 mg PLG microparticle or VC solution. Serum samples were collected from all tested mice on the day of immunization and at 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 weeks postimmunization. Sera were examined for vibriocidal antibodies by microtitration and Vibrio-specific serum IgG and IgM antibodies were assessed by the ELISA method. IgG and IgM antibodies to intact VC were detected in sera from all animals immunized with VC. The response was specific and of high magnitude. Significantly higher antibody responses were obtained when sera from both VC-loaded microparticles and VC-loaded microparticles physical mixed with amphotericin B immunized mice were titrated against VC. The immunogenicity of VC-loaded microparticles mixed with amphotericin B in evoking serum IgG and IgM responses was higher than that of VC-loaded microparticles only. These results demonstrate that VC-loaded microparticles physical mixed with amphotericin B and VC-loaded microparticles orally administered evoke Vibrio-specific serum IgG and IgM responses as well as vibriocidal antibody activity in mice. The VC incorporation, physicochemical characterization data, and the animal results obtained in this study may be relevant in optimizing the vaccine incorporation and delivery properties of these potential vaccine targeting carriers. (C) 2002 Elsevier Science B.V. All rights reserved. [References: 21]
机译:负载霍乱弧菌(VC)的微粒作为口服疫苗输送系统,其油相中含6%w / v聚(DL-丙交酯-共-乙交酯)(PLG)以及10%w / v PVP和5通过水包油包水型乳液/溶剂萃取技术得到水相中的%w / v NaCl。 VC成功地捕获在微粒中,捕集效率高达97.8%,装载量为55.4 +/- 6.9杯/毫克。粒径为3.8微米的微粒输送系统在核心区域(25.7 +/- 1.9马克杯/毫克)和表面(6.2 +/- 0.9马克杯/毫克)的VC含量分布不同。通过口服免疫在成年小鼠中评估了VC加载的微粒与PLG微粒或VC溶液相比的免疫原性潜力,其中小鼠接受了一剂20 mg VC加载的微粒或20 mg VC与两性霉素B物理混合的微粒对照组接受20 mg PLG微粒或VC溶液。在免疫当天和免疫后1、2、3、4、5、6、7、8、9和10周从所有测试的小鼠收集血清样品。通过微量滴定检查血清中的杀弧菌抗体,并通过ELISA方法评估弧菌特异性血清IgG和IgM抗体。在用VC免疫的所有动物的血清中均检测到了完整VC的IgG和IgM抗体。回应是具体的,而且幅度很大。当分别从VC加载的微粒和与两性霉素B免疫小鼠物理混合的VC加载的微粒中的血清针对VC进行滴定时,可获得更高的抗体反应。混合有两性霉素B的VC微粒引起的血清IgG和IgM反应的免疫原性高于仅VC微粒。这些结果表明,与两性霉素B物理混合的VC加载颗粒和口服VC加载颗粒在小鼠中引起弧菌特异性血清IgG和IgM反应以及杀弧菌抗体活性。在这项研究中获得的VC掺入,理化特性数据和动物结果可能与优化这些潜在疫苗靶向载体的疫苗掺入和递送特性有关。 (C)2002 Elsevier Science B.V.保留所有权利。 [参考:21]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号